A Randomized, Open-label, Parallel-Group, Single-dose, Biocomparability Study of the Pharmacokinetics of Abatacept (BMS-188667) Drug Products Using Active Pharmaceutical Ingredient Manufactured at Devens, MA Site Relative to Active Pharmaceutical Ingredient Manufactured at Lonza, NH in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2014
At a glance
- Drugs Abatacept (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 30 Mar 2012 Actual patient number added 223 according to ClinicalTrials.gov.
- 30 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.